Latest news

CEO statement

We are very enthusiastic about the rapid progress of our 4-1BB (CD137) antibody ATOR-1017. This is our third immuno-oncology asset to enter pre-clinical development and it demonstrates the strength and breadth of our pipeline. Read more

  • Donation for research on pancreatic cancer in memory of Jerker Löfgren

    In light of our ambition to develop novel cancer therapeutics, Alligator has received a donation for research on pancreatic cancer in memory of Jerker Löfgren. We are honored by the confidence shown for our research within immuno-oncology and our hope is that this will come to benefit patients with pancreatic cancer over time.